Sfoglia per Corso SCIENZE FARMACOLOGICHE SPERIMENTALI E CLINICHE
A MECHANISTIC APPROACH TO SYNAPTIC PLASTICITY AND COGNITION:SYNAPTIC STABILIZATION OF NMDARS THROUGH THE NOVEL INTERACTOR RABPHILIN-3A
2021
A SINGLE PRENATAL EXPOSURE TO POLY I:C INCREASES SUSCEPTIBILITY TO EPILEPSY IN THE ADULT OFFSPRING
2017
A SPINE TO NUCLEUS SIGNALING PATHWAY IN ALZHEIMER¿S DISEASE
2019
ACID SPHINGOMYELINASE AS A NEW PHARMACOLOGICAL TARGET IN THE ACUTE AND CHRONIC MUSCLE DAMAGE: AN ALTERNATIVE STRATEGY FOR MUSCULAR DYSTROPHIES THERAPY
2018
ACUTE AND PROLONGED EFFECT OF NEW TREATMENTS (LEVOSIMENDAN AND SACUBITRIL/VALSARTAN) IN HEART FAILURE: AN HOLISTIC EVALUATION
2019
ACUTE KETAMINE RESCUES CELLULAR AND MOLECULAR CHANGES INDUCED BY CHRONIC MILD STRESS IN VULNERABLE RATS
2018
ARHGAP22 DISRUPTION AFFECTS RAC1 SIGNALING PATHWAY AND RESULTS IN ALTERED FORMATION AND FUNCTION OF GLUTAMATERGIC SYNAPSES IN MOUSE HIPPOCAMPUS
2018
ASSESSMENT OF ENDOCRINE ACTIVE SUBSTANCES USINGIN SILICO AND REPORTER ASSAYS IN CELL AND MICE
2018
BETA-GLUCOCEREBROSIDASE MEDIATES MICROGLIAL NEUROPROTECTIVE FUNCTIONS: A POSSIBLE LINK BETWEEN PARKINSON'S AND GAUCHER'S DISEASES
2021
CHARACTERIZATION OF A NOVEL ANTIEPILEPTIC THERAPY BY TARGETING THE EEF2K/EEF2 PATHWAY
2018
CLINICAL AND EXPERIMENTAL EVIDENCES OF DIRECT VASCULAR EFFECT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9
2018
DECIPHERING THE ROLE OF ADIPOKINES ON PCSK9 REGULATION: EXPERIMENTAL EVIDENCE
2019
DECIPHERING THE ROLE OF SULFOTRANSFERASE 4A1 IN BRAIN DEVELOPMENT AND NEURONAL FUNCTIONING
2018
DIET, OXIDATIVE STRESS STATUS AND INFLAMMATION IN PATIENTS WITH CARDIOVASCULAR DISEASE: IN SEARCH FOR A LINK
2018
DYSREGULATION OF THE GPR17 RECEPTOR IN NEURO-INFLAMMATORY DISEASES: IMPLICATIONS FOR RE-MYELINATION IN MULTIPLE SCLEROSIS
2017
EFFECTS OF ATM KINASE INHIBITION ON BRAIN DEVELOPMENT
2018
ERALPHA: THE CROSSROAD BETWEEN METABOLIC FITNESS AND METABOLIC ILLNESS
2018
EXAMINING THE DIVERSE CONTRIBUTIONS OF EL TO SYSTEMIC LIPID METABOLISM
2017
EXAMINING THE DIVERSE CONTRIBUTIONS OF EL TO SYSTEMIC LIPID METABOLISM
2017
EXPLOITING DIVERSE DATA SOURCES TO INVESTIGATE EMERGING SAFETY ISSUES OF DRUGS IN POST-MARKETING PHASE: A RESEARCH FRAMEWORK FOR CLINICAL PHARMACOLOGIST
2021
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile